Evidence map›Paper›PMID 35573726›Full record

ArticleFrontiers in molecular biosciences2022

Molecular Insights and Prognosis Associated With RBM8A in Glioblastoma.

Lei Wei, Chun Zou, Liechun Chen, Yan Lin, Lucong Liang, Beiquan Hu, Yingwei Mao, Donghua Zou

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Lei WeiDepartment of Neurology, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, China.
Chun ZouDepartment of Neurology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Liechun ChenDepartment of Neurology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yan LinDepartment of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.
Lucong LiangDepartment of Neurology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Beiquan HuDepartment of Neurosurgery, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yingwei MaoDepartment of Biology, Pennsylvania State University, University Park, PA, United States.
Donghua ZouDepartment of Neurology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Guangxi Medical University · CNPennsylvania State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

candidate mRNAscox regressionglioblastomaoverall survivalRBM8A

Identifiers

PMID35573726
PMCPMC9098818
OpenAlexW4225091056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.